Concourse Financial Group Securities’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 77 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2295 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2292 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2344 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2351 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2318 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2348 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2372 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2403 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2338 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2031 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2215 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2189 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2394 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2426 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2383 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2356 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2311 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2180 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2096 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2182 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2073 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1767 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2227 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2274 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2138 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1667 |
|